# Safety and Immunogenicity Study of Three Candidate HIV-1 Vaccines, Administered in Combination to Healthy HIV-1 Uninfected Adults

> **NCT01151319** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 32 (actual)

## Conditions studied

- HIV-1 Infections

## Interventions

- **BIOLOGICAL:** ChAdV63.HIVconsv low dose.
- **BIOLOGICAL:** ChAdV63.HIVconsv high dose.
- **BIOLOGICAL:** pSG2.HIVconsv
- **BIOLOGICAL:** MVA.HIVconsv
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01151319
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01151319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01151319, "Safety and Immunogenicity Study of Three Candidate HIV-1 Vaccines, Administered in Combination to Healthy HIV-1 Uninfected Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01151319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*